Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04739215Phase 4Unknown
Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF
Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction
PrincipalinvestigatorStart date: 2021-01-15
NCT04649034Completed
Intraventricular Stasis In Cardiovascular Disease
Dilated CardiomyopathyHypertrophic CardiomyopathyStroke+1 more
PrincipalinvestigatorStart date: 2020-11-24
NCT03415789Completed
Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy
Dilated CardiomyopathyStrokeThrombosis
PrincipalinvestigatorStart date: 2018-02-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04739215Phase 4PrincipalInvestigator

Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF

Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction
Unknown
NCT04649034PrincipalInvestigator

Intraventricular Stasis In Cardiovascular Disease

Dilated CardiomyopathyHypertrophic CardiomyopathyStroke+1 more
Completed
NCT03415789PrincipalInvestigator

Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy

Dilated CardiomyopathyStrokeThrombosis
Completed

All 3 trials loaded